Suzhou Ribo Life Science Co., Ltd (Ribolia)

Suzhou Ribo Life Science Co., Ltd (Ribolia) is a leading biotechnology research company dedicated to the development of innovative oligonucleotide therapeutics, aiming to significantly improve human health and wellbeing. With a strong commitment to addressing unmet clinical needs, Ribo leverages cutting-edge RNAi technologies and a comprehensive oligonucleotide therapeutic platform.

Established in 2007, Suzhou Ribo Life Science Co., Ltd. (Ribolia) integrates the complete set of technologies to support the full lifecycle of oligonucleotide therapeutics, from early research and development to commercialization. The company's primary address is Room 210, 2 / F, Building 1, No. 28 Houtun Road, Haidian District, Beijing, 100102, CN, with additional locations including MedicMedicinaregatan 8A, Gothenburg, 41390, SE and No. 168, Yuanfeng Road, Yushan Town, Kunshan City, Jiangsu 215300, CN.

Suzhou Ribo Life Science Co., Ltd (Ribolia)'s mission is to ensure that China's oligonucleotide therapeutics serve the world. The company is actively expanding its capabilities and reach within the global biotechnology landscape. The management team at Suzhou Ribo Life Science Co., Ltd (Ribolia) are currently working to complete additional information about the company, to further highlight their offerings and expertise. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform.